Rapid Diagnostic Testing with BCID2 Panel Improves Time to Optimal Therapy

Many patients with bloodstream infections achieved optimal therapy within 48 hours using the Biofire Blood Culture ...

JUNE 3, 2025

FDA Approves Defencath to Reduce CRBSIs From Hemodialysis

The FDA approved Defencath to reduce catheter-related bloodstream infections in adults with renal failure who are ...

NOVEMBER 30, 2023

National Guidance, Local Implementation: Considerations for Local Blood Culture Identification Guideline Development Using the BIOFIRE^® Blood Culture Identification 2 (BCID2) Panel

The article outlines considerations for the implementation of locally developed testing and treatment guidelines ...

MARCH 31, 2023

More Bloodstream Infections Seen Among Hispanic Dialysis Patients

All people on dialysis are at risk for bloodstream infections, but a recent report found that Hispanics have the ...

FEBRUARY 6, 2023

CLABSI Surveillance and Home Infusion: Are We Prepared?

Many home infusion therapy staff receive no formal training on performing central line?associated bloodstream ...

JANUARY 27, 2023

Bloodstream Infections Complicate COVID-19 Risks

Secondary bloodstream infections may pose a significant risk to patients with severe COVID-19, according to a ...

FEBRUARY 5, 2021

Catheter Safeguards at Hospitals Reduce Infections, Save Money

Precautions, while costly to implement, ultimately cut health care spending by millions.

JANUARY 11, 2017

Outpatient Bloodstream Infections Costly in Kids With Cancer

Median charge for central line–associated bloodstream infection is $37,000 for six-day hospitalization.

SEPTEMBER 1, 2016